Price $82.24 |
Market Cap
41.14B
|
Sector Health Care |
Div. Growth
11.40%
|
|
P/E
39.6
|
P/B
4.91
|
P/S
3.51
|
Dividend %
1.40%
|
|
P/CF
-
|
P/FCF
54.5
|
Op. Cash Flow
1.97M
|
FCF
1.5
|
|
Op. Margin
12.20%
|
Net Margin
9.00%
|
ROE
12.60%
|
ROI
8.60%
|
|
ROA
5.40%
|
EPS Growth
8.00%
|
Current Ratio
2.5
|
Debt/Equity
66.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $31.82 | - | - | 11.47B | Strong Buy |
| Novavax, Inc. (NVAX) | $209.68 | - | - | 11.17B | Strong Buy |
| Natus Medical Inc (NTUS) | $27.49 | - | - | 906.5M | Strong Buy |
| Myriad Genetics, Inc. (MYGN) | $29.73 | - | - | 2.23B | Strong Buy |
| Molecular Templates Inc (MTEM) | $8.91 | - | - | 504.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
